Vice President - Chemistry, Manufacturing and Controls
Vice President - Chemistry, Manufacturing and Controls
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Tvardi Therapeutics Ord Shs?
The top five shareholders of Tvardi Therapeutics Ord Shs are: Dr. Susan Shiff, Ph.D.
What is the biggest source of revenue for Tvardi Therapeutics Ord Shs?
In 2026Q4, the Other revenue business generated the highest revenue for Tvardi Therapeutics Ord Shs, amounting to 1.32M and accounting for 51.50% of total revenue.